Rhythm jumps after late-stage trial win; BofA upgrades (update)
Rhythm Pharma (RYTM) stock rises as lead asset setmelanotide succeeds in a Phase 3 trial for a rare obesity type, causing an ...
Zacks Investment Research on MSN7h
Is Life Time Group Holdings (LTH) Stock Outpacing Its Consumer Discretionary Peers This Year?
Investors interested in Consumer Discretionary stocks should always be looking to find the best-performing companies in the group. Has Life Time Group Holdings, Inc. (LTH) been one of those stocks ...